Brief: ROVI 9M Revenue EUR 564.6 Million

Laboratorios Farmaceuticos Rovi

07/11/2024 06:40

Nov 07 (Reuters) - ROVI 9M free cash flow EUR 31.4 million.
* 9M EBITDA EUR 167.2 million
* 9M net income EUR 113.5 million
* 9M EBIT EUR 146.6 million